There is not the sufficient antiviral for A H1N1 in Mexico: Ssa

[tetano]

Mexico, DF. - The Secretary of Health, Salom?n Chertorivski, admitted that there is lack of the antiviral one against the influenza AH1N1, Tamifl?, in the pharmacies of the Country. It indicated that the product is not exhausted in Mexico, since the manufacturer has it, but has not been sent to the pharmacies because they have not requested it. He said that before it, Tamifl? asked to some private pharmacies to request to guarantee that the population has access. He announced that the pharmacy of the General Hospital surtir? of free form the antiviral one, any time a medical recipe appears in return. He affirmed that all the medical units of the country are provided with Tamifl?, and that the reservations are of 1.4 million treatments, additional to other 300 thousand that have already been distributed in the states of the Country.

http://www.provincia.com.mx/2012/01/no-hay-suficiente-antiviral-a-h1n1-en-mexico-ssa/

 

[tetano]

Re: There is no the sufficient antiviral for A H1N1 in Mexico: Ssa

Re: There is no the sufficient antiviral for A H1N1 in Mexico: Ssa

Pharmacies blame wholesalers for the shortage of Tamiflu in the country

The National Association of Pharmacies of Mexico (Anafarmex) admitted that in 24 thousand pharmacies that exist in Mexico there registers a "worrying" shortage of oseltamivir, known as Tamiflu — medicine that the influenza treats, especially the A/H1N1-, motive for which the dispensers exhorted the wholesalers to whom they improve his distribution before the growth of contagions.
Antonio Pascual, president of the Anafarmex, told to MILLENIUM that the shortage in centers of selling, big and boys, initiated from January and now the Tamiflu counts no establishment in his shelf with, although the company manufacturer (Roche) stopped in clear that it has produced sufficient medicine.

“ The problem focaliza in the two biggest distributors of the country (House Nadro and House Saba) that without any explanation have been slow during all this month in supplying to the pharmacies. We have requested the intervention of the Secretary of Health because it is a question of a curative medicine, it is the only alternative to fight the influenza A/H1N1 ”, he said Paschal.
The Swiss company Roche duplicated his production of the antiviral Tamiflu or oseltamivir, on having spent from 200 to 400 million treatments, to constitute a strategic reservation that it allows Mexico and different nations to treat the persons infected in winter epoch.

http://www.milenio.com/cdb/doc/impreso/9101172